Chemical Compound

naltrexone

CAS Registry Number 16590-41-3
Back to search Request a Quote
naltrexone chemical structure
Primary Record

naltrexone

In stock
7,828 g
Purity
98.7 %
CAS
16590-41-3

Compound Identifiers & Properties

CAS
16590-41-3
PubChem CID
5360515
SMILES
C1CC1CN2CC[C@]34[C@@H]5C(=O)CC[C@]3([C@H]2CC6=C4C(=C(C=C6)O)O5)O
Canonical SMILES
O=C1CC[C@@]2(O)[C@H]3Cc4ccc(O)c5c4[C@@]2(CCN3CC2CC2)[C@H]1O5

Names & Synonyms

  • naltrexone
  • Vivitrol
  • Vivitrex
  • Celupan
  • ReVia
  • Naltrexona
  • Naltrexone Hcl
  • Naltrexonum
  • Nemexin
  • Depade
  • Naltrel
  • Trexan
  • Depotrex
  • Adepend
  • Nalorex
  • Opizone
  • Naltrexone hydrochloride
  • Trexal
  • 16590-41-3
  • MorViva
  • Naltrexone Depot
  • (-)-Naltrexone
  • N-Cyclopropylmethylnoroxymorphone
  • (-)naltrexone
  • Naltrexonum [INN-Latin]
  • Naltrexona [INN-Spanish]
  • Vivitrol (TN)
  • naltrexone (ReVia)
  • XR-NTX
  • NALTREXONE [MI]
  • RefChem:56739
  • Naltrexone [USAN:INN:BAN]
  • Naltrexone base anhydrous
  • NALTREXONE [INN]
  • Naltrexone (USAN/INN)
  • Prestwick0_000116
  • Prestwick1_000116
  • Prestwick2_000116
  • Prestwick3_000116
  • 5S6W795CQM
  • CCRIS 3506
  • CHEBI:7465
  • EN-1639A FREE BASE
  • NALTREXONE [HSDB]
  • NALTREXONE [USAN]
  • UNII-5S6W795CQM
  • DTXSID4046313
  • NALTREXONE [VANDF]
  • D0PG8O
  • Epitope ID:549278
  • HSDB 6750
  • Naltrexone [USAN:BAN:INN]
  • NALTREXONE [MART.]
  • NALTREXONE [USP-RS]
  • NALTREXONE [WHO-DD]
  • UNII-Z6375YW9SF
  • US9107954, naltrexone
  • C20H23NO4.ClH
  • SCHEMBL34681
  • UM-792
  • BSPBio_000132
  • cyclopropylmethylnoroxymorphone
  • DTXCID2026313
  • MLS000069607
  • orb611377
  • BIDD:GT0405
  • CHEMBL19019
  • EINECS 240-649-9
  • PTI-555
  • SPBio_002071
  • DQCKKXVULJGBQN-XFWGSAIBSA-N
  • BPBio1_000146
  • CCRIS 1168
  • GTPL1639
  • IBS therapy, Pain Therapeutics
  • Naltrexone hydrochloride [USP]
  • SYK-59
  • ZINC1773
  • N-Cyclopropylmethyl-14-hydroxydihydromorphinone
  • En 1639A
  • NALTREXONE [ORANGE BOOK]
  • Naltrexone hydrochloride [USAN]
  • NSC-758439
  • SCHEMBL29366199
  • BDBM60212
  • C20H23NO4
  • cid_5485201
  • BRN 3596648
  • EN1639A
  • N07BB04
  • Naltrexone hydrochloride dihydrate
  • PTI-901
  • MFCD00242996
  • C20-H23-N-O4.Cl-H
  • cyclopropylmethyl(dihydroxy)[?]one
  • HMS2089O11
  • EN-1639A [AS HYDROCHLORIDE]
  • Naltrexone (1 mg/mL in Methanol)
  • BCP07022
  • EN-1639A
  • EX-A4863
  • NIH 8503
  • EINECS 240-723-0
  • Tox21_112007
  • BDBM50000787
  • C20-H23-N-O4
  • EBC-26662
  • Naltrexone (sustained release), DAS
  • PDSP2_000847
  • AKOS015994596
  • Naltrexone (1.0 mg/mL in Methanol)
  • Tox21_112007_1
  • 17-(Cyclopropylmethyl)-4,5alpha-epoxy-3,14-dihydroxymorphinan-6-one
  • CID5360515
  • CS-0880
  • DB00704
  • HS-0002
  • J9.044A
  • Naltrexone (sustained release), elbion
  • NSC 758439
  • 17-(Cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxymorphinan-6-one
  • SMP1_000206
  • NCGC00024427-03
  • NCGC00024427-04
  • NCGC00024427-05
  • NCGC00162274-02
  • AC-36726
  • AN-12941
  • DA-55992
  • HY-76711
  • LS-92094
  • Naltrexone (low-dose), Pain Therapeutics
  • SC-94535
  • SMR000058767
  • CAS-16590-41-3
  • NS00009185
  • C07253
  • D05113
  • N-Cyclopropylmethyl-noroxymorphone hydrochloride
  • W-5099
  • (4R,4aS,7aR,12bS)-3-(cyclopropylmethyl)-4a,9-dihydroxy-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one
  • 88088-EP2270005A1
  • 88088-EP2275420A1
  • 88088-EP2298761A1
  • 88088-EP2298776A1
  • 88088-EP2305648A1
  • AB00174152-14
  • AB00174152_17
  • Naltrexone depot (injectable suspension), elbion
  • EN300-19748946
  • Q409587
  • A1209045
  • Irritable bowel syndrome therapy, Pain Therapeutics
  • BRD-K88172511-003-19-5
  • BRD-K88172511-003-20-3
  • BRD-K88172511-003-21-1
  • BRD-K88172511-310-03-8
  • Morphinan-6-one, 17-(cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxy-, (5alpha)-
  • 3,14-dihydroxy-17-(cyclopropylmethyl)-4,5alpha-epoxymorphinan-6-one
  • Naltrexone depot (injectable suspension), DrugAbuse Sciences
  • (1S,5R,13R,17S)-4-(cyclopropylmethyl)-10,17-dihydroxy-12-oxa-4-azapentacyclo[9.6.1.0^{1,13}.0^{5,17}.0^{7,18}]octadeca-7(18),8,10-trien-14-one
  • (4R,4As,7aR)-3-(cyclopropylmethyl)-4a,9-dihydroxy-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one
  • Morphinan-6-one, 17-(cyclopropylmethyl)-4,5-alpha-epoxy-3,14-dihydroxy-
  • Morphinan-6-one, 17-(cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxy-, (5.alpha.)-
  • Naltrexone (once-monthly controlled-release, Medisorb), Alkermes
  • Naltrexone (transdermal, alcohol/opioid dependence), Syntropharma
  • Opioid antagonists (irritable bowel syndrome), Pain Therapeutics
  • (5-alpha)-17-(Cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxymorphinan-6-one
  • 16676-29-2
  • 17-(Cyclopropylmethyl)-3,14-dihydroxy-5alpha-4,5-epoxymorphinan-6-one
  • 4,5alpha-Epoxy-3,14beta-dihydroxy-17-(cyclopropylmethyl)morphinan-6-one
  • Morphinan-6-one, 17-(cyclopropylmethyl)-4,5.alpha.-epoxy-3,14-dihydroxy-
  • Morphinan-6-one,17-(cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxy-, (5a)-
  • (5alpha)-17-(Cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxymorphinan-6-one hydrochloride
  • 17-(Cyclopropylmethyl)-4,5-alpha-epoxy-3,14-dihydroxy-morphinan-6-one hydrochloride
  • 17-(Cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxmorphinan-6-one, (5.alpha.)-
  • Morphinan-6-one, 17-(cyclopropylmethyl)-4,5-alpha-epoxy-3,14-dihydroxy-, hydrochloride
  • Naltrexone (polymer microcapsule depot, opioid addiction/alcohol dependency), Biotek
  • Naltrexone solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material
  • (-)-Naltrexone; 1-N-Cyclopropylmethyl-7,8-dihydro-14-hydroxynormorphinone; Depotrex; EN 1639; N-Cyclopropylmethylnoroxymorphone; Naltrel; Naltrexone; Nemexin; Trexonil; UM 792; Vivitrex; Vivitrol; (5alpha)-17-(Cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxymorphinan-6-one; Morphinan-6-one, 17-(cyclopropylmethyl)-4,5alpha-epoxy-3,14-dihydroxy- (8CI)
  • (1S,5R,13R,17S)-4-(cyclopropylmethyl)-10,17-dihydroxy-12-oxa-4-azapentacyclo(9.6.1.0^(1,13).0^(5,17).0^(7,18))octadeca-7(18),8,10-trien-14-one
  • (1S,5R,13R,17S)-4-(cyclopropylmethyl)-10,17-dihydroxy-12-oxa-4-azapentacyclo(9.6.1.01,13.05,17.07,18)octadeca-7(18),8,10-trien-14-one
  • (1S,5R,13R,17S)-4-(cyclopropylmethyl)-10,17-dihydroxy-12-oxa-4-azapentacyclo[9.6.1.01,13.05,17.07,18]octadeca-7,9,11(18)-trien-14-one
  • (4R,4aS,7aR,12bS)-3-(cyclopropylmethyl)-4a,9-bis(oxidanyl)-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7-one;hydrochloride
  • (4R,4aS,7aR,12bS)-3-(cyclopropylmethyl)-4a,9-dihydroxy-2,3,4,4a,5,6-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7(7aH)-one
  • (4R,4aS,7aR,12bS)-3-(Cyclopropylmethyl)-4a,9-dihydroxy-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro(3,2-e)isoquinolin-7-one
  • (4R,4aS,7aR,12bS)-3-(cyclopropylmethyl)-4a,9-dihydroxy-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7-one;hydrochloride
  • (4R,4aS,7aR,12bS)-4a,9-Dihydroxy-2,3,4,4a,5,6,7,7a-octahydro-3-cyclopropylmethyl-4,12-methano-1H-benzofuro[3,2-e]isoquinoline-7-one
  • 240-649-9
  • Morphinan-6-one, 17-(cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxy-, hydrochloride, (5-alpha)-
  • Morphinan-6-one, 17-(cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxy-, hydrochloride, (5.alpha.)-